NTRA
Natera, Inc.
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$436.00
+2.73%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- 317.70x
- P/S forward
- 19.04x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 34.50x
- Price / sales
- 23.22x
- Price / cash flow
- 275.36x
Enterprise value
- Enterprise value
- $62.0B
- EV / sales
- 22.90x
- EV / EBITDA
- -346.90x
- EV / EBIT
- -214.02x
- Market cap
- $62.8B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026